Clinical Trial Update: Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Temelimab after Rituximab treatment in relapsing forms of multiple sclerosis has completed and results are posted. The sponsor is GeNeu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Temelimab (temelimab)

Snippet

Sponsor: GeNeuro Innovation SAS | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2024-11-07